Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
UBS Group AG and its related entities have ceased to be substantial shareholders in Australian Clinical Labs Ltd as of October 24, 2024. This change in shareholding might influence market perceptions and investor interest in the company. Investors may want to monitor Australian Clinical Labs for further developments in its shareholder composition.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.